We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+40.75%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$94.5M
AUM Growth
+$26.4M
Cap. Flow
+$359K
Cap. Flow %
0.38%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
LVO icon
LiveOne
LVO
+$359K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 78.93%
2 Communication Services 20.86%
3 Industrials 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$23.5M
$70M 74.08%
99,113
LVO icon
2
LiveOne
LVO
$66M
$19.7M 20.86%
366,354
+6,060
+2% +$359K
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$4.19M 4.43%
31,858
SENS icon
4
Senseonics Holdings Inc
SENS
$254M
$391K 0.41%
7,980
FSNN
5
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$203K 0.21%
155,069

Similar funds

Rho Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Rho Capital Partners held 5 positions worth $94.5M, up 39% from $68.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 73% a quarter earlier, followed by Communication Services and Industrials.

  • Rho Capital Partners added most to LiveOne in Q1 2019, an estimated $359K increase.
  • Rho Capital Partners's ten largest holdings make up 100% of its $94.5M portfolio in Q1 2019.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q1 2019.
  • Rho Capital Partners's portfolio value rose 39% quarter-over-quarter to $94.5M.

Based on Rho Capital Partners's 13F filing for Q1 2019, filed 14 May 2019.